Allakos Inc (ALLK)

7.40
-0.03(-0.40%)
Pre Market
7.31
-0.09(-1.22%)
- Real-time Data
  • Volume:
    574,640
  • Day's Range:
    7.16 - 7.53
  • 52 wk Range:
    2.54 - 8.73

ALLK Overview

Prev. Close
7.43
Day's Range
7.16-7.53
Revenue
-
Open
7.47
52 wk Range
2.54-8.73
EPS
-6.69
Volume
574,640
Market Cap
630.51M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,072,262
P/E Ratio
-1.10
Beta
0.491
1-Year Change
4.67%
Shares Outstanding
85,203,597
Next Earnings Date
Feb 28, 2023
What is your sentiment on Allakos?
or
Market is currently closed. Voting is open during market hours.

Allakos Inc News

Allakos Inc Analysis

Allakos Inc Company Profile

Allakos Inc Company Profile

Allakos Inc. is a clinical stage biotechnology company. The Company is developing therapeutics, which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory, and proliferative diseases. Its advanced antibodies are lirentelimab (AK002) and AK006. AK002 selectively targets both mast cells and eosinophils, two types of white blood cells that are widely distributed in the body and play a central role in the inflammatory response. It is developing AK002 for the treatment of eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic duodenitis (EoD), atopic dermatitis, chronic spontaneous urticaria and additional indications. AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. It also developed a formulation of lirentelimab for subcutaneous (SC) administration. The Company is also developing additional antibodies targeting inhibitory receptors expressed on key disease-driving immune cells.

Read More

Analyst Price Target

Average6.83 (-7.66% Downside)
High20.00
Low2.00
Price7.40
No. of Analysts9
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuySell
Technical IndicatorsNeutralStrong BuyStrong BuyStrong SellNeutral
SummaryNeutralStrong BuyStrong BuyNeutralNeutral
  • This is trying to get dressed for the party which has yet to be announced.
    0
    • Go to up!
      0
      • Internal holding 1.25% only. CEO sold out his shares on 12/2/2021 at $73. He didn’t buy anything. if this is bottom, he will invest again. Let him buy again before you put the money. Trust me $4-5 within 45 days.
        2
        • Your 45 days are up. Barely dipped below 6. any more predictions?
          0
        • Your 45 days are up. Barely dipped below 6. any more predictions?
          0
        • he is getting close
          0
      • $4-5 end of the month . keep the screenshot .
        1
        • so that didn't happen. hope it will go up again! |
          0
      • in few month may be...be prepared for either direction. as the stock has not bounced back immediately. atleast untill next quarter report.
        0
        • when do you guys think it will go to 20$ as they say?
          0
          • how many are planning to hold this stock long term?
            0
            • when you see this and you buy it you will be rich soon
              2
              • Or they go bankrupt and you lose everything
                0
            • Hope everyone is ok! Terrible thing to happen!
              0
              • Printing, so cheap
                0